Covers Saxenda for patients meeting specific criteria with annual caps of $2,500-4,500
Cocaine Only limited clinical evidence is available for GLP-1RAs in cocaine misuse: a small ( N = 13) proof-of-concept trial across 2 days showed that exenatide compared with placebo did not reduce the number of self-administered cocaine infusions 115 , while a case series of 3 individuals with cocaine-use disorder highlighted the feasibility and safety of using the same drug over 6 weeks, although no efficacy measures were reported 116
* MB Core: A blend including Acacia, Lemon Bioflavonoids, Berberine, Hesperidin, Eggplant, and Chromium that activates GLP-1 in specialized L-cells, promoting fullness via the gut-brain axis
Glucagon-like peptide-1 receptor (GLP-1) agonists continue to surge in popularity largely due to their ability to stabilize blood sugar, curb appetite, and assist with weight loss and weight management